Australia has benefited enormously from innovations enabled by the commercial scale and investment capacity of the US healthcare market. Yet the debate in Australia often reflects an incomplete understanding of how that market works and its core strengths beyond a capacity to innovate. …
Australia, the US, and their different choices about health system trade-offs
April 17, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Sanofi volunteers confront homelessness at Vinnies CEO Sleepout
June 19, 2026 - - Latest News -
Infectious diseases across the lifespan are a hidden burden beyond the acute episode
June 19, 2026 - - Latest News -
Gilead rushes remdesivir to Uganda to support Ebola response
June 19, 2026 - - Latest News -
Rhapsido approved in Australia as first oral targeted option for chronic spontaneous urticaria
June 18, 2026 - - Latest News -
Is China's international benchmarking a bigger short-term risk to medicines access?
June 18, 2026 - - Latest News -
Life sciences leaders brace for class action wave as dispute risks multiply
June 18, 2026 - - Latest News -
Australia's life sciences sector welcomes new CGT concession but urges RDTI fixes
June 18, 2026 - - Latest News